SunWay Biotech Co., LTD. (TPEX:1271)
Taiwan
· Delayed Price · Currency is TWD 51.40
-1.20 (-2.28%)
Mar 9, 2026, 2:40 PM CST
SunWay Biotech Co., LTD. Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,104 | 4,728 | 4,568 | 1,598 | 2,041 | - | Upgrade
|
| Market Cap Growth | -38.59% | 3.52% | 185.85% | -21.71% | - | - | Upgrade
|
| Enterprise Value | 2,969 | 4,693 | 4,567 | 1,154 | 1,698 | - | Upgrade
|
| Last Close Price | 51.40 | 76.55 | 128.32 | 42.69 | 51.23 | - | Upgrade
|
| PE Ratio | 36.71 | 39.88 | 99.10 | 53.19 | 12.10 | - | Upgrade
|
| PS Ratio | 3.26 | 4.87 | 8.00 | 3.76 | 5.37 | - | Upgrade
|
| PB Ratio | 0.96 | 1.45 | 1.43 | 5.55 | 3.73 | - | Upgrade
|
| P/TBV Ratio | 3.76 | 5.60 | 6.14 | 5.89 | 3.84 | - | Upgrade
|
| P/FCF Ratio | 31.06 | 116.10 | 468.66 | 37.52 | 13.51 | - | Upgrade
|
| P/OCF Ratio | 15.29 | 30.13 | 81.59 | 37.52 | 12.70 | - | Upgrade
|
| EV/Sales Ratio | 3.12 | 4.84 | 8.00 | 2.71 | 4.46 | - | Upgrade
|
| EV/EBITDA Ratio | 15.92 | 24.94 | 71.61 | 26.09 | 9.59 | - | Upgrade
|
| EV/EBIT Ratio | 27.20 | 33.29 | 87.67 | 29.41 | 10.15 | - | Upgrade
|
| EV/FCF Ratio | 29.71 | 115.23 | 468.61 | 27.09 | 11.24 | - | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.08 | 0.09 | 0.25 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 2.92 | 1.09 | 3.79 | 1.56 | 0.01 | 0.02 | Upgrade
|
| Debt / FCF Ratio | 5.44 | 5.99 | 29.48 | 1.67 | 0.02 | 0.01 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.01 | -0.02 | -0.18 | -0.63 | -0.63 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.87 | -0.26 | -1.17 | -1.19 | -1.94 | -2.14 | Upgrade
|
| Net Debt / FCF Ratio | -1.37 | -1.22 | -7.68 | -1.23 | -2.28 | -1.62 | Upgrade
|
| Asset Turnover | 0.24 | 0.26 | 0.27 | 0.78 | 0.68 | 0.76 | Upgrade
|
| Inventory Turnover | 1.71 | 2.24 | 2.53 | 3.22 | 1.31 | 1.09 | Upgrade
|
| Quick Ratio | 1.47 | 2.65 | 3.09 | 1.57 | 7.40 | 7.34 | Upgrade
|
| Current Ratio | 1.93 | 3.69 | 4.00 | 2.36 | 8.72 | 9.34 | Upgrade
|
| Return on Equity (ROE) | 2.64% | 3.67% | 2.64% | 7.51% | 33.55% | 33.82% | Upgrade
|
| Return on Assets (ROA) | 1.73% | 2.34% | 1.54% | 4.52% | 18.69% | 18.99% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.81% | 3.71% | 2.56% | 14.15% | 89.01% | 63.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.10% | 4.00% | 1.50% | 13.50% | 30.60% | 27.10% | Upgrade
|
| Earnings Yield | 2.73% | 2.51% | 1.01% | 1.88% | 8.27% | - | Upgrade
|
| FCF Yield | 3.22% | 0.86% | 0.21% | 2.67% | 7.40% | - | Upgrade
|
| Dividend Yield | 2.53% | 1.74% | 0.77% | 7.46% | 8.35% | - | Upgrade
|
| Payout Ratio | - | 50.09% | 92.54% | 21.42% | 54.95% | - | Upgrade
|
| Buyback Yield / Dilution | -20.41% | -97.22% | -51.54% | 41.13% | -5.76% | 3.72% | Upgrade
|
| Total Shareholder Return | -17.89% | -95.48% | -50.77% | 48.59% | 2.59% | 3.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.